E-Poster | Pharma Sciences | Drug Delivery

Electronic Drug Delivery Systems Market to Reach Over USD 18.81 Billion by 2031 Fueled by 7.06 Percent CAGR Growth and Rise in Chronic Disease Management

2025-06-16 - 2025-06

"Global Electronic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Wearable Infusion Pumps, Auto Injectors, Injection Pens, and Inhalers), By Application (Diabetes, Cardiovascular Disease (CVD), Respiratory Disorders, Multiple Sclerosis ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)- Market Outlook And Industry Analysis 2031"

CRISM Therapeutics wins prestigious drug delivery award

2025-06-10 - 2025-06

CRISM Therapeutics Corporation (AIM:CRTX), a UK-based drug delivery company, has been awarded the Drug Delivery and Translational Research Journal Outstanding Paper Award by the Controlled Release Society (CRS). The company’s research on ChemoSeed, a local chemotherapy delivery technology, earned the accolade for its potential to improve treatment for glioblastoma, a type of brain cancer.

Revolutionising drug delivery through emerging technologies

2025-06-02 - 2025-06

Innovative technologies are reshaping drug delivery by addressing the limitations of traditional methods and enhancing patient care. Among these advancements, needle-free injection technology shines as a breakthrough in significantly improving patient compliance.

Intelligent deep learning model for targeted cancer drug delivery

2025-05-31 - 2025-05

Nanotechnology and information communication technology (ICT) are being combined to develop innovative drug delivery systems for targeted sites, such as tumor cells. The particulate targeted drug delivery (PTDD) system involves drugs containing nanoparticles embedded in nanoscale devices (referred to as bio-nanomachines) that can cross vascular barriers, resulting in an increased concentration of the drug in the targeted cell or tumor.

Biohybrid Microrobots for Deep-Tissue Drug Penetration:

2025-05-21 - 2025-05

A novel biohybrid microrobot has been developed, consisting of jellyfish stinging capsules, which act as natural nanoinjectors for efficient penetration and delivery, assembled onto an active Janus particle. These microrobots demonstrate potential for deep tissue drug delivery, with in vitro studies showing successful penetration and delivery of preloaded drugs to targeted cancer spheroids and live Caenorhabditis elegans.

pH Sensitive Drug Delivery Systems: A Review

2025-05-20 - 2025-05

pH Sensitive Drug Delivery Systems (PSDDS) are gaining importance as these systems deliver the drug at specific time as per the pathophysiological need of the disease, resulting in improved patient therapeutic efficacy and compliance. Diseases wherein PSDDS are promising include asthma, peptic ulcer, cardiovascular diseases, cancer and hypertension. The specific time that patients take their medication is very important as it has significant impact on treatment success.

Balancing Chemical and Supramolecular Stability in OEGylated Supramolecular Polymers for Systemic Drug Delivery

2025-05-17 - 2025-05

The chemical conjugation of poly(ethylene glycol) (PEG) to therapeutic agents, known as PEGylation, is a well-established strategy for enhancing drug solubility, chemical stability, and pharmacokinetics. Here, we report on a class of supramolecular polymeric prodrugs by utilizing oligo(ethylene glycol) (OEG) to modify the hydrophobic anticancer drug camptothecin (CPT).

Self-Tuning Hydrogels for Controlled Release:

2025-05-17 - 2025-05

Researchers have developed a hydrogel formulation strategy for self-regulating, post-injection network evolution enabled by exchange of functional molecules with the physiological environment, achieving controlled cargo release over both short and long durations. This approach minimizes burst release while preserving sustained-release profiles, offering a novel strategy for precise cargo delivery in biomedical applications.

Sustainability in Drug Delivery:

2025-05-16 - 2025-05

The drug delivery sector is experiencing a wave of innovation, marked by the rise of advanced delivery systems and a growing emphasis on sustainability. These trends are expected to significantly shape the future of drug delivery in 2025 and beyond.

Advanced Drug Delivery Systems (ADDS) Market Growth:

2025-05-15 - 2025-05

The global market for advanced drug delivery systems is projected to exceed $395 billion by 2030, driven by the rising demand for targeted and personalized therapies. Monoclonal antibodies are set to be the fastest-growing carrier segment, with an 8.9% CAGR, propelled by antigen-specific therapies.

Magnetic Microrobots for Targeted Therapies:

2025-05-14 - 2025-05

A magnetically guided microrobotic drug delivery system has been developed, capable of precise navigation under physiological conditions. This platform integrates a clinical electromagnetic navigation system, a custom-designed release catheter, and a dissolvable capsule for accurate therapeutic delivery. In vitro tests showed precise navigation in human vasculature models, and in vivo experiments confirmed tracking under fluoroscopy and successful navigation in large animal models.

Long-Lasting Injectable Contraceptive:

2025-05-13 - 2025-05

Scientists have developed a new type of contraceptive implant that can be administered via injection and self-assembles in the body, potentially offering long-term drug delivery without the need for surgical procedures. While not yet tested in humans, the proof-of-concept experiments in rats showed that the drug release could be sustained for at least 97 days.

Ultrasound-Activated 3D Implants:

2025-05-12 - 2025-05

Researchers have developed a technique using focused ultrasound waves and specialty bioinks to create 3D drug-delivery implants inside the body. This method, tested in animal models, enables localized gel formation slightly above body temperature and allows real-time ultrasound imaging to guide implant shape and function. A notable experiment involved delivering chemotherapy via printed drug-loaded hydrogels into a mouse bladder, resulting in significantly improved tumor response compared to direct drug injections.

Remote-Controlled Drug Release via Magnetic Fibers

2025-05-09 - 2025-05

A novel drug release platform has been developed using electrospun magnetic fibers combining drugs, magnetic nanoparticles, and mesoporous silica nanoparticles. Controlled drug release is achieved via alternating magnetic fields, offering precise control over drug release patterns. This system shows promise for applications like transdermal pain management and oncological drug delivery.

Long-Lasting Injectable Contraceptive Implant

2025-05-08 - 2025-05

Scientists have developed a new type of contraceptive implant that can be administered via injection and self-assembles in the body, potentially offering long-term drug delivery without the need for surgical procedures. Proof-of-concept experiments in rats showed that the drug release could be sustained for at least 97 days. Further research and human studies are planned within the next three to five years.

Advancements in Capsule Technology

2025-05-07 - 2025-05

In 2025, advancements in manufacturing technology and polymer science are revolutionizing the capsule industry, driving the widespread adoption of cellulose-based capsules. These innovations address raw material concerns, enhance active pharmaceutical ingredient (API) release and stability, and offer formulators significant advantages.

Biohybrid Microrobots for Deep-Tissue Drug Penetration

2025-05-06 - 2025-05

Scientists have engineered biohybrid microrobots combining jellyfish stinging capsules and Janus particles. These microrobots can penetrate deep tissues and deliver drugs effectively. The capsules are activated by specific enzymes, triggering tubule ejection and release of preloaded molecules, demonstrating potential for targeted cancer therapies.

Self-Tuning Hydrogels for Controlled Drug Release

2025-05-03 - 2025-05

A new hydrogel formulation strategy has been introduced to achieve controlled cargo release over both short and long durations. By tuning network viscoelasticity, researchers optimized rheological properties to minimize burst release while preserving sustained-release profiles. In vitro and in vivo studies demonstrated reduced burst release and comparable sustained-release to unmodified control formulations, highlighting a novel strategy for precise cargo delivery in biomedical applications.

Magnetic Microrobots for Targeted Therapies

2025-05-02 - 2025-05

Researchers have developed magnetically guided microrobots capable of precise navigation within the human body. These microrobots integrate a clinical electromagnetic navigation system, a custom-designed release catheter, and a dissolvable capsule for accurate therapeutic delivery. In vitro tests demonstrated precise navigation in human vasculature models, and in vivo experiments confirmed successful tracking and navigation in large animal models. This innovation offers a promising solution for precise targeted drug delivery

Oral GLP-1 Receptor Agonist for Weight Loss and Diabetes

2025-04-30 - 2025-04

Eli Lilly's development of orforglipron, an oral GLP-1 receptor agonist, has shown promising results in late-stage trials for weight loss and diabetes management. The pill demonstrated significant efficacy and a favorable safety profile comparable to existing injectable obesity drugs. Eli Lilly plans to seek regulatory approval for orforglipron as an obesity treatment by the end of 2025 and for diabetes in 2026.

Magnetic Microrobots for Precision Drug Delivery

2025-04-29 - 2025-04

A team of researchers has introduced magnetically guided microrobotic systems designed for precise drug delivery. These microrobots can navigate human vasculature under physiological conditions, enabling targeted therapy with minimal systemic exposure. In vitro tests demonstrated precise navigation in human vasculature models, and in vivo experiments confirmed successful navigation in large animal models, marking a significant step toward clinical applications.

Targeted Nanoparticle Delivery Across the Blood-Brain Barrier

2025-04-28 - 2025-04

Researchers at Oregon State University have developed dual peptide-functionalized polymeric nanocarriers capable of crossing the blood-brain barrier. This advancement enables targeted delivery of anti-inflammatory IRAK4 inhibitors to the hypothalamus in mice, significantly improving treatment outcomes for cancer cachexia—a condition causing severe weight and muscle loss. The approach resulted in a 94% increase in food intake and better retention of body weight and muscle mass. This technology holds promise for treating other neurological disorders such as Alzheimer's disease, Parkinson’s disease, and multiple sclerosis.

Self-Assembling Injectable Implants for Long-Term Drug Release

2025-04-25 - 2025-04

Scientists have developed a novel contraceptive implant administered via injection that self-assembles in the body, potentially offering long-term drug delivery without surgical procedures. In rat models, the implant sustained drug release for at least 97 days. This method, involving micro-crystals of synthetic progesterone in a water-resistant solvent, could be adapted for other treatments such as HIV, tuberculosis, schizophrenia, and chronic pain, especially in regions with limited medical infrastructure.

Freeze-dried exosomes could transform drug delivery and storage

2025-04-19 - 2025-04

The Gourdie laboratory had a problem of its own making. The lab at the Fralin Biomedical Research Institute at VTC has spent years exploring how microscopic containers naturally found in raw cow's milk—called exosomes—can be used to carry medicine through the body.

Agno Pharma’s Particle Sciences, Inc. Achieves ISO 13485:2016 Certification

2025-04-17 - 2025-04

Agno Pharma recently announced its subsidiary, Particle Sciences, Inc., has earned ISO 13485:2016 certification from National Quality Assurance, U.S.A. (NQA). This achievement underscores Particle Sciences’

Webinar on Pharmaceutical Sciences and Drug Delivery

useful links

Latest News